798 related articles for article (PubMed ID: 34352250)
1. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
Schwartz A; Nir O; Toussia-Cohen S; Leibovich L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Levin EG; Lustig Y; Regev-Yochay G; Yinon Y
Am J Obstet Gynecol; 2021 Nov; 225(5):577-579. PubMed ID: 34352250
[No Abstract] [Full Text] [Related]
2. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
Front Immunol; 2021; 12():777103. PubMed ID: 34804068
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study.
Charepe N; Gonçalves J; Juliano AM; Lopes DG; Canhão H; Soares H; Serrano EF
BMC Pregnancy Childbirth; 2021 Sep; 21(1):632. PubMed ID: 34535094
[TBL] [Abstract][Full Text] [Related]
4. Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination.
Kelly JC; Carter EB; Raghuraman N; Nolan LS; Gong Q; Lewis AN; Good M
Am J Obstet Gynecol; 2021 Jul; 225(1):101-103. PubMed ID: 33798480
[No Abstract] [Full Text] [Related]
5. Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination.
Gonçalves J; Juliano AM; Charepe N; Alenquer M; Athayde D; Ferreira F; Archer M; Amorim MJ; Serrano F; Soares H
Cell Rep Med; 2021 Dec; 2(12):100468. PubMed ID: 34873588
[TBL] [Abstract][Full Text] [Related]
6. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
Juncker HG; Mulleners SJ; van Gils MJ; de Groot CJM; Pajkrt D; Korosi A; van Goudoever JB; van Keulen BJ
J Hum Lact; 2021 Aug; 37(3):477-484. PubMed ID: 34176363
[TBL] [Abstract][Full Text] [Related]
7. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
[TBL] [Abstract][Full Text] [Related]
8. Role of maternal COVID-19 vaccination in providing immunological protection to the newborn.
Jorgensen SCJ; Burry L; Tabbara N
Pharmacotherapy; 2022 Jan; 42(1):58-70. PubMed ID: 34816467
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Specific Antibodies Against SARS-CoV-2 in Breast Milk of Lactating Women Vaccinated With an mRNA Vaccine.
Esteve-Palau E; Gonzalez-Cuevas A; Guerrero ME; Garcia-Terol C; Alvarez MC; Casadevall D; Diaz-Brito V
JAMA Netw Open; 2021 Aug; 4(8):e2120575. PubMed ID: 34379127
[TBL] [Abstract][Full Text] [Related]
11. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
[TBL] [Abstract][Full Text] [Related]
12. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.
Beharier O; Plitman Mayo R; Raz T; Nahum Sacks K; Schreiber L; Suissa-Cohen Y; Chen R; Gomez-Tolub R; Hadar E; Gabbay-Benziv R; Jaffe Moshkovich Y; Biron-Shental T; Shechter-Maor G; Farladansky-Gershnabel S; Yitzhak Sela H; Benyamini-Raischer H; Sela ND; Goldman-Wohl D; Shulman Z; Many A; Barr H; Yagel S; Neeman M; Kovo M
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34014840
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
Perl SH; Uzan-Yulzari A; Klainer H; Asiskovich L; Youngster M; Rinott E; Youngster I
JAMA; 2021 May; 325(19):2013-2014. PubMed ID: 33843975
[TBL] [Abstract][Full Text] [Related]
14. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
Front Immunol; 2021; 12():726960. PubMed ID: 34671348
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
Massarweh A; Eliakim-Raz N; Stemmer A; Levy-Barda A; Yust-Katz S; Zer A; Benouaich-Amiel A; Ben-Zvi H; Moskovits N; Brenner B; Bishara J; Yahav D; Tadmor B; Zaks T; Stemmer SM
JAMA Oncol; 2021 Aug; 7(8):1133-1140. PubMed ID: 34047765
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
[TBL] [Abstract][Full Text] [Related]
17. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.
Levine-Tiefenbrun M; Yelin I; Katz R; Herzel E; Golan Z; Schreiber L; Wolf T; Nadler V; Ben-Tov A; Kuint J; Gazit S; Patalon T; Chodick G; Kishony R
Nat Med; 2021 May; 27(5):790-792. PubMed ID: 33782619
[TBL] [Abstract][Full Text] [Related]
18. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
19. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
20. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
